Dissecting The TMPRSS6 Regulation Of Iron Homeostasis
Funder
National Health and Medical Research Council
Funding Amount
$613,311.00
Summary
Iron overload and anaemia are two of the most significant health problems affecting humans. Understanding how the body regulates iron levels is key to our understanding of these disorders and to the future development of new therapies. This research is aimed at understanding how a hormone produced in the liver called hepcidin that maintains iron balance is regulated. This research may lead to novel therapies aimed at correcting the iron balance in conditions of iron overload or anaemia
A Novel Nanoparticulate Iron Supplement And Its Effect On The Gastrointestinal Tract.
Funder
National Health and Medical Research Council
Funding Amount
$671,995.00
Summary
Iron deficiency and iron deficiency anaemia are major global health issues. Currently available iron supplements can lead to gastrointestinal side effects. We have developed a new type of oral iron supplement that (in animal studies) is as effective as conventional treatments, but without their limitations. In this project we will investigate the effect of this supplement on the gastrointestinal tract to ensure its safety and to provide preliminary data for future clinical trials in humans.
This proposal is aimed at improving the health of people with “Disorders of Iron Metabolism”. It focuses on the iron-related diseases hereditary haemochromatosis and colorectal cancer, as well as liver disease, chronic kidney disease and malnutrition. Outcomes from these studies are expected to identify how iron metabolism is impaired, the clinical consequences and new strategies for the prevention and treatment of iron-related diseases.
EXAMINING THE RELATIONSHIP BETWEEN MATRIPTASE-2 AND HEMOJUVELIN, TWO ESSENTIAL REGULATORS OF IRON HOMEOSTASIS
Funder
National Health and Medical Research Council
Funding Amount
$533,541.00
Summary
The control of iron levels is important in health and well being. Too little can lead to iron deficiency and anaemia, conversly too much can lead to haemochromatosis and tissue damage. We will examine the role of two proteins, matriptase-2 and hemojuvelin that when mutated cause iron deficiency or iron overload respectively. We will study how these proteins interact and work in opposite directions to control iron levels. The results will help to develop new therapeutics for iron disorders.
Too little or too much of the essential element iron is the cause of some of the most common disorders affecting humans. These include iron overload, anaemia, and anaemia of chronic disease. This project examines the genes and the roles they play in regulating iron levels in the body, and the consequences to the individuals when they are mutated. Ultimately I intend to develop therapeutics and diagnostics which will help early diagnosis and effective treatment of these disorders.